-
1Academic Journal
Authors: A. Kh. Zabirova, I. S. Bakulin, A. G. Poydasheva, D. Yu. Lagoda, M. N. Zakharova, E. V. Gnedovskaya, N. A. Suponeva, M. A. Piradov, А. Х. Забирова, И. С. Бакулин, А. Г. Пойдашева, Д. Ю. Лагода, М. Н. Захарова, Е. В. Гнедовская, Н. А. Супонева, М. А. Пирадов
Contributors: The study was conducted as part of the research project “New technologies of neurorebilitation” (registration number 123120100062-0)., Исследование выполнено в рамках научно-исследовательской работы «Новые технологии нейрореабилитации» (регистрационный номер 123120100062-0)
Source: Neurology, Neuropsychiatry, Psychosomatics; Vol 17, No 2 (2025); 36-43 ; Неврология, нейропсихиатрия, психосоматика; Vol 17, No 2 (2025); 36-43 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2025-2
Subject Terms: задняя теменная кора, cognitive impairment, transcranial magnetic stimulation, intermittent theta burst stimulation, multitarget stimulation, dorsolateral prefrontal cortex, posterior parietal cortex, когнитивные нарушения, транскраниальная магнитная стимуляция, стимуляция интермиттирующими тета-вспышками, мультитаргетная стимуляция, дорсолатеральная префронтальная кора
File Description: application/pdf
Relation: https://nnp.ima-press.net/nnp/article/view/2480/1789; Lakin L, Davis BE, Binns CC, et al. Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms – A Narrative Review. Neurol Ther. 2021 Jun;10(1):75-98. doi:10.1007/s40120-021-00239-2. Epub 2021 Apr 20.; Ruano L, Portaccio E, Goretti B, et al. Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Mult Scler. 2017 Aug;23(9):1258-67. doi:10.1177/1352458516674367. Epub 2016 Oct 13.; Renner A, Baetge SJ, Filser M, et al. Characterizing cognitive deficits and potential predictors in multiple sclerosis: A large nationwide study applying Brief International Cognitive Assessment for Multiple Sclerosis in standard clinical care. J Neuropsychol. 2020 Sep;14(3):347-69. doi:10.1111/jnp.12202. Epub 2020 Feb 13.; De Meo E, Portaccio E, Giorgio A, et al. Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis. JAMA Neurol. 2021 Apr;78(4):414-25. doi:10.1001/jamaneurol.2020.4920; Hojsgaard Chow H, Schreiber K, Magyari M, et al. Progressive multiple sclerosis, cognitive function, and quality of life. Brain Behav. 2018 Jan;8(2):e00875. doi:10.1002/brb3.875; Moccia M, Lanzillo R, Palladino R, et al. Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression. Mult Scler. 2016 Apr;22(5):659-67. doi:10.1177/1352458515599075. Epub 2015 Sep 11.; Pitteri M, Romualdi C, Magliozzi R, et al. Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study. Mult Scler. 2017 May;23(6):848-54. doi:10.1177/1352458516665496. Epub 2016 Aug 15.; Забирова АХ, Бакулин ИС, Пойдашева АГ и др. Когнитивные нарушения и методы их терапии у пациентов с рассеянным склерозом. Альманах клинической медицины. 2023;51(2):110-25. doi:10.18786/2072-0505-2023-51-009; Zhang J, Cortese R, De Stefano N, Giorgio A. Structural and Functional Connectivity Substrates of Cognitive Impairment in Multiple Sclerosis. Front Neurol. 2021 Jul;12:671894. doi:10.3389/fneur.2021.671894; Rocca MA, Schoonheim MM, Valsasina P, et al. Task-and resting-state fMRI studies in multiple sclerosis: From regions to systems and time-varying analysis. Current status and future perspective. Neuroimage Clin. 2022 Jun;35:103076. doi:10.1016/j.nicl.2022.103076. Epub 2022 Jun 6.; Jandric D, Doshi A, Scott R, et al. A Systematic Review of Resting-State Functional MRI Connectivity Changes and Cognitive Impairment in Multiple Sclerosis. Brain Connect. 2022 Mar;12(2):112-33. doi:10.1089/brain.2021.0104; Miller E, Morel A, Redlicka J, et al. Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis. Curr Neuropharmacol. 2018;16(4):475-83. doi:10.2174/1570159X15666171109132650; Motavalli A, Majdi A, Hosseini L, et al. Pharmacotherapy in multiple sclerosis-induced cognitive impairment: A systematic review and meta-analysis. Mult Scler Relat Disord. 2020 Nov;46:102478. doi:10.1016/j.msard.2020.102478. Epub 2020 Aug 30.; Chen MH, Chiaravalloti ND, DeLuca J. Neurological update: cognitive rehabilitation in multiple sclerosis. J Neurol. 2021 Dec;268(12):4908-14. doi:10.1007/s00415-021-10618-2. Epub 2021 May 24.; Taylor LA, Mhizha-Murira JR, Smith L, et al. Memory rehabilitation for people with multiple sclerosis. Cochrane Database Syst Rev. 2021 Oct;10(10):CD008754. doi:10.1002/14651858.CD008754.pub4; Пирадов МА, Бакулин ИС, Забирова АХ и др. Транскраниальная магнитная стимуляция в клинической и исследовательской практике. Пирадов МА, редактор. Москва: Горячая линия – Телеком; 2024. 584 с.; Лагода ДЮ, Бакулин ИС, Пойдашева АГ и др. фМРТ-направленная ритмическая транскраниальная магнитная стимуляция в терапии когнитивных расстройств при церебральной микроангиопатии. Анналы клинической и экспериментальной неврологии. 2024;18(2):24-33. doi:10.17816/ACEN.1087; Lanza G, Fisicaro F, Dubbioso R, et al. A comprehensive review of transcranial magnetic stimulation in secondary dementia. Front Aging Neurosci. 2022 Sep;14:995000. doi:10.3389/fnagi.2022.995000.; Lefaucheur JP, Aleman A, Baeken C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018). Clin Neurophysiol. 2020 Feb;131(2):474-528. doi:10.1016/j.clinph.2019.11.002. Epub 2020 Jan 1.; Sabbagh M, Sadowsky C, Tousi B, et al. Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease. Alzheimers Dement. 2020 Apr;16(4):641-50. doi:10.1016/j.jalz.2019.08.197. Epub 2020 Jan 16.; Rounis E, Huang YZ. Theta burst stimulation in humans: a need for better understanding effects of brain stimulation in health and disease. Exp Brain Res. 2020 Aug;238(7-8):1707-14. doi:10.1007/s00221-020-05880-1. Epub 2020 Jul 15.; Wischnewski M, Schutter DJ. Efficacy and Time Course of Theta Burst Stimulation in Healthy Humans. Brain Stimul. 2015 JulAug;8(4):685-92. doi:10.1016/j.brs.2015.03.004. Epub 2015 Mar 26.; Hulst HE, Goldschmidt T, Nitsche MA, et al. rTMS affects working memory performance, brain activation and functional connectivity in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2017 May;88(5):386-94. doi:10.1136/jnnp-2016-314224. Epub 2016 Dec 14.; Agüera E, Caballero-Villarraso J, Feijoo M, et al. Clinical and Neurochemical Effects of Transcranial Magnetic Stimulation (TMS) in Multiple Sclerosis: A Study Protocol for a Randomized Clinical Trial. Front Neurol. 2020 Aug;11:750. doi:10.3389/fneur.2020.00750; Blanchard C, De Dios Perez B, Tindall T, et al. Trial protocol: Feasibility of neuromodulation with connectivity-guided intermittent theta-burst stimulation for improving cognition in multiple sclerosis. Open Med (Wars). 2023 Sep;18(1):20230814. doi:10.1515/med-2023-0814; Evdoshenko E, Laskova K, Shumilina M, et al. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in the Russian Population. J Int Neuropsychol Soc. 2022 May;28(5):503-10. doi:10.1017/S1355617721000722. Epub 2021 Jun 16.; Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971 Mar;9(1):97-113. doi:10.1016/0028-3932(71)90067-4; Chung SW, Rogasch NC, Hoy KE, et al. Impact of different intensities of intermittent theta burst stimulation on the cortical properties during TMS-EEG and working memory performance. Hum Brain Mapp. 2018 Feb;39(2):783-802. doi:10.1002/hbm.23882. Epub 2017 Nov 9.; Scarpina F, Tagini S. The Stroop Color and Word Test. Front Psychol. 2017 Apr;8:557. doi:10.3389/fpsyg.2017.00557; Mueller ST, Piper BJ. The Psychology Experiment Building Language (PEBL) and PEBL Test Battery. J Neurosci Methods. 2014 Jan;222:250-9. doi:10.1016/j.jneumeth.2013.10.024. Epub 2013 Nov 20.; Haatveit BC, Sundet K, Hugdahl K, et al. The validity of d prime as a working memory index: results from the “Bergen n-back task”. J Clin Exp Neuropsychol. 2010 Oct;32(8):871-80. doi:10.1080/13803391003596421; Gavrilov YV, Shkilnyuk GG, Valko PO, et al. Validation of the Russian version of the Fatigue Impact Scale and Fatigue Severity Scale in multiple sclerosis patients. Acta Neurol Scand. 2018 Nov;138(5):408-16. doi:10.1111/ane.12993; Супонева НА, Бакулин ИС, Пойдашева АГ и др. Частотно-зависимый эффект транскраниальной стимуляции тета-вспышками префронтальной коры на когнитивные функции. Вестник РГМУ. 2023;(6):60-8. doi:10.24075/vrgmu.2023.045; Patel R, Silla F, Pierce S, et al. Cognitive functioning before and after repetitive transcranial magnetic stimulation (rTMS): A quantitative meta-analysis in healthy adults. Neuropsychologia. 2020 Apr;141:107395. doi:10.1016/j.neuropsychologia.2020.107395. Epub 2020 Mar 4.; Senczyszyn A, Szczesniak D, Wieczorek T, et al. Improvement of working memory in older adults with mild cognitive impairment after repetitive transcranial magnetic stimulation – a randomized controlled pilot study. Front Psychiatry. 2023 Nov;14:1196478. doi:10.3389/fpsyt.2023.1196478; Jia Y, Xu L, Yang K, et al. Precision Repetitive Transcranial Magnetic Stimulation Over the Left Parietal Cortex Improves Memory in Alzheimer's Disease: A Randomized, Double-Blind, Sham-Controlled Study. Front Aging Neurosci. 2021 Jun;13:693611. doi:10.3389/fnagi.2021.693611; Gaede G, Tiede M, Lorenz I, et al. Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue. Neurol Neuroimmunol Neuroinflamm. 2017 Dec;5(1):e423. doi:10.1212/NXI.0000000000000423; Mori F, Ljoka C, Magni E, et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. J Neurol. 2011 Jul;258(7):1281-7. doi:10.1007/s00415-011-5924-1. Epub 2011 Feb 1.; Korzhova J, Bakulin I, Sinitsyn D, et al. High-frequency repetitive transcranial magnetic stimulation and intermittent theta-burst stimulation for spasticity management in secondary progressive multiple sclerosis. Eur J Neurol. 2019 Apr;26(4):680-e44. doi:10.1111/ene.13877. Epub 2019 Jan 15.; Matias-Guiu JA, Gonzalez-Rosa J, Hernandez MA, et al. Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial. BMJ Open. 2024 Jan;14(1):e078661. doi:10.1136/bmjopen2023-078661